aluminum has been researched along with Heart Failure in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Enzan, H; Furihata, M; Iguchi, M; Lee, GH; Mori, K; Ohnishi, H; Ohtsuki, Y | 1 |
| Go, AS; Gurwitz, JH; Hsu, J; Lane, K; Platt, R; Yang, J | 1 |
| Drüeke, T; Galle, P; Nogues, C; Roth, A | 1 |
3 other study(ies) available for aluminum and Heart Failure
| Article | Year |
|---|---|
Investigation of aluminum and iron deposition on metaplastic bones in three patients with diffuse pulmonary ossification.
Topics: Aged; Aged, 80 and over; Aluminum; Bone and Bones; Duodenal Neoplasms; Heart Failure; Humans; Iron; Lung; Lung Diseases; Male; Metaplasia; Ossification, Heterotopic; Thoracic Surgery, Video-Assisted; Tomography, X-Ray Computed | 2015 |
Comparative effectiveness of beta-adrenergic antagonists (atenolol, metoprolol tartrate, carvedilol) on the risk of rehospitalization in adults with heart failure.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Aluminum; Atenolol; California; Carbazoles; Carvedilol; Confidence Intervals; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Heart Failure; Humans; Male; Metoprolol; Middle Aged; Patient Readmission; Propanolamines; Proportional Hazards Models; Retrospective Studies; Risk Factors; Tartrates; Time Factors; Treatment Outcome | 2007 |
Multiorgan aluminium deposits in a chronic haemodialysis patient. Electron microscope and microprobe studies.
Topics: Aluminum; Brain Diseases; Cardiomyopathy, Dilated; Heart Failure; Humans; Lysosomes; Male; Middle Aged; Renal Dialysis; Tissue Distribution | 1984 |